Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L van de Velde

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Acta Clinica Belgica|January 31, 2008
Acute myeloid leukaemia of mixed megakaryocytic and erythroid origin: a case report and review of the literatureL Daniëls, K Guerti, K Vermeulen, et al.
Journal of Assisted Reproduction and Genetics|January 6, 2021
Time intervals between semen production, initiation of analysis, and IUI significantly influence clinical pregnancies and live birthsU Punjabi, H Van Mulders, L Van de Velde, et al.
Leukemia Research|April 26, 2016
Medical costs of treatment and survival of patients with acute myeloid leukemia in BelgiumA L Van de Velde, P Beutels, E L Smits, et al.
Physiological Reports|September 22, 2025
Determinants of renal flow reserve in adult patients with and without renal artery stenosisT A Bouwmeester, L van de Velde, D Collard, et al.
The Netherlands Journal of Medicine|October 23, 2020
New diagnostic and treatment strategies in renal artery stenosis: a promising pursuit or disappointment foretold?L van de Velde, D Collard, W Spiering, et al.
Blood|August 24, 2017
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemiaSébastien Anguille, Ann L Van de Velde, Evelien L Smits, et al.
Journal of Hematology & Oncology|March 20, 2025
Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcomeZwi N Berneman, Maxime De Laere, Paul Germonpré, et al.
Journal of Hematology & Oncology|January 24, 2025
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcomeZwi N Berneman, Maxime De Laere, Paul Germonpré, et al.
Orphanet Journal of Rare Diseases|April 16, 2025
COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNetPablo Velasco Puyo, Soteroula Christou, Saveria Campisi, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Acta Clinica Belgica|January 31, 2008
Acute myeloid leukaemia of mixed megakaryocytic and erythroid origin: a case report and review of the literatureL Daniëls, K Guerti, K Vermeulen, et al.
Journal of Assisted Reproduction and Genetics|January 6, 2021
Time intervals between semen production, initiation of analysis, and IUI significantly influence clinical pregnancies and live birthsU Punjabi, H Van Mulders, L Van de Velde, et al.
Leukemia Research|April 26, 2016
Medical costs of treatment and survival of patients with acute myeloid leukemia in BelgiumA L Van de Velde, P Beutels, E L Smits, et al.
Physiological Reports|September 22, 2025
Determinants of renal flow reserve in adult patients with and without renal artery stenosisT A Bouwmeester, L van de Velde, D Collard, et al.
The Netherlands Journal of Medicine|October 23, 2020
New diagnostic and treatment strategies in renal artery stenosis: a promising pursuit or disappointment foretold?L van de Velde, D Collard, W Spiering, et al.
Blood|August 24, 2017
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemiaSébastien Anguille, Ann L Van de Velde, Evelien L Smits, et al.
Journal of Hematology & Oncology|March 20, 2025
Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcomeZwi N Berneman, Maxime De Laere, Paul Germonpré, et al.
Journal of Hematology & Oncology|January 24, 2025
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcomeZwi N Berneman, Maxime De Laere, Paul Germonpré, et al.
Orphanet Journal of Rare Diseases|April 16, 2025
COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNetPablo Velasco Puyo, Soteroula Christou, Saveria Campisi, et al.
Pageof 3